byl719 and Retinal-Detachment

byl719 has been researched along with Retinal-Detachment* in 1 studies

Other Studies

1 other study(ies) available for byl719 and Retinal-Detachment

ArticleYear
Long-Term Evaluation of MEK Inhibitor Retinal Toxicity With Multimodal Imaging.
    Ophthalmic surgery, lasers & imaging retina, 2016, Volume: 47, Issue:1

    MEK inhibitor chemotherapy, used in various malignancies, has been reported to be associated with serous retinal detachments. This study reports serial multimodal imaging focused primarily on infrared reflectance and spectral-domain optical coherence tomography (SD-OCT) in the monitoring of MEK inhibitor retinal toxicity. The benefit of OCT angiography in understanding the pathophysiology of MEK inhibitor toxicity is also shown.

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Female; Fluorescein Angiography; Follow-Up Studies; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Middle Aged; Multimodal Imaging; Optical Imaging; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Retina; Retinal Detachment; Thiazoles; Tomography, Optical Coherence

2016